The net profit for the year-past time standing at Rs 531 crore and the income from operation is reported at Rs 2,259 crore.
In addition, the board of director of the company also announced a Divorce of Rs 30 per share for shareholders for financial year 2024-25. For the purpose of shareholders, the company is recovering July 25 as the date of the record.
Clockwise, the pat rose at 12.28%, from Rs 594 crore in the third quarter of FY25. Even in the face of income, the company registers a 10.3% growth of Qoq, rise from Rs 2,297 crore.
In addition, Divi Laboratories report a joint income of Rs 2,671 crore for the quarter ending March 31,382 crore in the same quarter last year.
For the current quarter, the company has a forex gain of RS 10 crore as against a forex loss of Rs 2 crore for the corresponding quarter of the previous year.meanwhile, for the full financial year 2025, the company’s Pat stood at RS 2,191 crore, versus Rs 1,600 crore for the corresponding quarter for the corresponding quarter Of the previous financial year, marking a growth of 36.9% yoy.Read again: What is the meaning of reduced CLSA for future indusind bank?
Regarding its Capex programs, the company announced that the unit III Greenfield Project at Ontimamidi Village, near the footsteps, Andhra Pradesh, commercial operations began in the current quarter.
The Divi labs extend the assets valuing Rs 1,118 crore during the financial year, which Rs 755 crore of unit-III in the tire.
Friday, parts of Divi Laboratories closed 1.16% higher than Rs 6,281.35 in BSE.
(Matan -re: Recommendations, suggestions, views and opinions given to experts themselves. This does not represent views of economic times)
